National Academy of Sciences | 150 Year Anniversary

Questions? Call 800-624-6242

| Items in cart [0]

The National Academies Press

PAPERBACK
price:$59.75
add to cart

Rights & Permissions

topleft topright

Medicare: New Directions in Quality Assurance Proceedings (1991)
Institute of Medicine (IOM)

Citation Manager

. "19. A Legislator's Response to the Institute of Medicine Report." Medicare: New Directions in Quality Assurance Proceedings. Washington, DC: The National Academies Press, 1991.

Please select a format:

BibTeX EndNote RefMan


Page
160
bottomleft bottomright

The following HTML text is provided to enhance online readability. Many aspects of typography translate only awkwardly to HTML. Please use the page image as the authoritative form to ensure accuracy.


Medicare: New Directions in Quality Assurance

cal dependency services. I visualize that the basic benefit package would be subsidized in some manner and include some prescribed cost sharing. Any other health services purchased beyond the basic benefit covered package would be the individual's or employer's particular choice.

Having a national-level benefit package means that all persons are covered, including those who may be heavy users of the health care system. This, in itself, would address many of the currently unresolved access problems for the uninsured or for those who have high-cost illnesses and diseases and are unable to obtain coverage for pre-existing conditions.

My reform package begins with catastrophic coverage. We learned through the unsuccessful efforts to add catastrophic coverage to Medicare that we need to educate the public on what they are buying through insurance and to make them aware of what they are not buying. Americans need to understand the role they are playing—through purchasing insurance products with extensive benefit packages—in supporting and promoting the high cost of health care in America. The dissatisfaction with health care cost is as much my problem as a consumer as it is the problem of the insurance companies, the doctors, the hospitals, or anybody else. Until we, the consumers, understand that we are all part of the problem, we, the reformists, are not really going to be able to do all of the things we need to do to correct the problems.

CLOSING REMARKS

We need happy doctors in order to have quality care. Doctors must feel that they are doing what attracted them to practice medicine in the first place. For this to happen, the consumer—the patient—needs to better understand his or her role in the health care system.

REFERENCE

Institute of Medicine. Medicare: A Strategy for Quality Assurance. Volumes I and II. Lohr, K.N., ed. Washington, D.C.: National Academy Press, 1990.

Page
160
Front Matter (R1-R10)
Part 1: Introduction (1-2)
1. Introduction (3-6)
2. The Institute of Medicine Report (7-14)
Part 2: New Directions: More Professionalism, Less Regulation (15-17)
3. The Committee View (18-21)
4. A Response (22-26)
Part 3: New Directions: Organization- and System-Focused Quality Improvement (27-30)
5. The Committee View (31-36)
6. A Response (37-44)
Part 4: New Directions: Improved Decision-Making by Patients and Clinicians (45-47)
7. The Committee View (48-53)
8. A Response (54-58)
Part 5: New Directions: A Patient Outcomes Orientation (59-62)
9. The Committee View (63-72)
10. A Response (73-78)
Part 6: New Directions: Public Accountability and Program Evaluation (79-81)
11. The Committee View (82-85)
12. A Response (86-90)
Part 7: Confronting Special Implementation Issues (91-95)
13. The Epidemiology of Quality Problems (96-104)
14. Legal Concerns (105-115)
15. Translating the Institute of Medicine Report (116-126)
Part 8: New Directions: The Research, Training, and Capacity Building Agendas (127-129)
16. Research and Capacity Building: Issues Raised by the Institute of Medicine Report (130-139)
17. The Research Agenda: An Outside View (140-144)
18. The Training and Capacity Building Agendas: An Outside View (145-150)
Part 9: Response to the Institute of Medicine Report Recommendations (151-154)
19. A Legislator's Response to the Institute of Medicine Report (155-160)
20. A Legislator's Response to the Institute of Medicine Report (161-166)
21. A Physician's Response to the Institute of Medicine Report (167-173)
22. An Administration Response to the Institute of Medicine Report from the Agency for Health Care Policy and Research (174-178)
23. An Administration Response to the Institute of Medicine Report from the Health Care Financing Administration (179-185)
24. A Peer Review Organization Response to the Institute of Medicine Report (186-190)
Part 10: Where Do We Go From Here? (191-193)
25. Where Do We Go From Here? (194-197)
26. Where Do We Go From Here? (198-204)
List of Authors (205-208)